353 related articles for article (PubMed ID: 29996864)
1. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.
Ferrara G; Mastrangelo G; Barone P; La Torre F; Martino S; Pappagallo G; Ravelli A; Taddio A; Zulian F; Cimaz R;
Pediatr Rheumatol Online J; 2018 Jul; 16(1):46. PubMed ID: 29996864
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
[TBL] [Abstract][Full Text] [Related]
3. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
van Dijkhuizen EH; Wulffraat NM
Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416
[TBL] [Abstract][Full Text] [Related]
4. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.
Constantin T; Foeldvari I; Anton J; de Boer J; Czitrom-Guillaume S; Edelsten C; Gepstein R; Heiligenhaus A; Pilkington CA; Simonini G; Uziel Y; Vastert SJ; Wulffraat NM; Haasnoot AM; Walscheid K; Pálinkás A; Pattani R; Györgyi Z; Kozma R; Boom V; Ponyi A; Ravelli A; Ramanan AV
Ann Rheum Dis; 2018 Aug; 77(8):1107-1117. PubMed ID: 29592918
[TBL] [Abstract][Full Text] [Related]
5. A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
Bava C; Mongelli F; Pistorio A; Bertamino M; Bracciolini G; Dalprà S; Davì S; Lanni S; Muratore V; Pederzoli S; Rosina S; Schiappapietra B; Suffia C; Varnier G; Verazza S; Giancane G; Consolaro A; Ravelli A
Pediatr Rheumatol Online J; 2019 Jul; 17(1):50. PubMed ID: 31345226
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritis.
van Straalen JW; Akay G; Kouwenberg CV; de Roock S; Kalinina Ayuso V; Wulffraat NM; de Boer J; Swart JF
RMD Open; 2023 Apr; 9(2):. PubMed ID: 37094979
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW;
Trials; 2014 Jan; 15():14. PubMed ID: 24405833
[TBL] [Abstract][Full Text] [Related]
8. [Methotrexate in the therapy of juvenile idiopathic arthritis].
Holzinger D; Frosch M; Föll D
Z Rheumatol; 2010 Aug; 69(6):496-504. PubMed ID: 20632181
[TBL] [Abstract][Full Text] [Related]
9. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
McMahan R; Balfe LM; Greene L
J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
[TBL] [Abstract][Full Text] [Related]
10. Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis.
Pohjankoski H; Kautiainen H; Lauri JV; Puolakka K; Rantalaiho V
Clin Rheumatol; 2020 Jan; 39(1):263-268. PubMed ID: 31346886
[TBL] [Abstract][Full Text] [Related]
11. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
[TBL] [Abstract][Full Text] [Related]
12. [Recommendations for the use of methotrexate in patients with juvenile idiopathic arthritis].
Calvo I; Antón J; López Robledillo JC; de Inocencio J; Gamir ML; Merino R; Lacruz L; Camacho M; Rua MJ; Bustabad S; Díaz Cordovés-Rego G
An Pediatr (Barc); 2016 Mar; 84(3):177.e1-8. PubMed ID: 26077957
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
[TBL] [Abstract][Full Text] [Related]
14. When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?
Polat MC; Çelikel E; Tekin ZE; Kurt T; Kaplan MM; Güngörer V; Tekgöz N; Sezer M; Karagöl C; Coşkun S; Öner N; Sezer S; Acar BÇ
Eur J Pediatr; 2024 Jun; 183(6):2725-2731. PubMed ID: 38554171
[TBL] [Abstract][Full Text] [Related]
15. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
[TBL] [Abstract][Full Text] [Related]
16. Use of methotrexate in juvenile idiopathic arthritis.
Ramanan AV; Whitworth P; Baildam EM
Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
[TBL] [Abstract][Full Text] [Related]
17. The use of methotrexate in children with rheumatic diseases.
Gutiérrez-Suárez R; Burgos-Vargas R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
[TBL] [Abstract][Full Text] [Related]
18. Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind.
Scott C; Chan M; Slamang W; Okong'o L; Petty R; Laxer RM; Katsicas MM; Fredrick F; Chipeta J; Faller G; Pileggi G; Saad-Magalhaes C; Wouters C; Foster HE; Kubchandani R; Ruperto N; Russo R
Clin Rheumatol; 2019 Feb; 38(2):563-575. PubMed ID: 30267356
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
Funk RS; Chan MA; Becker ML
Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
